Provided by Tiger Trade Technology Pte. Ltd.

Insmed

126.89
-1.9100-1.48%
Volume:665.61K
Turnover:84.78M
Market Cap:27.71B
PE:-31.04
High:128.78
Open:127.13
Low:124.29
Close:128.80
52wk High:212.75
52wk Low:90.39
Shares:218.38M
Float Shares:216.82M
Volume Ratio:0.66
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0882
EPS(LYR):-6.4200
ROE:-87.22%
ROA:-22.17%
PB:36.58
PE(LYR):-19.76

Loading ...

Analysts’ Top Healthcare Picks: Insmed (INSM), Illumina (ILMN)

TIPRANKS
·
Jul 17

Analysts Offer Insights on Healthcare Companies: Insmed (INSM), AbCellera Biologics (ABCL) and DBV Technologies SA – American (DBVT)

TIPRANKS
·
Jul 17

Insmed Announces Positive 12-Month TPIP PAH Data

TIPRANKS
·
Jul 17

Matt Phipps Reiterates Buy on Insmed, Citing Strong TPIP PAH Data, Solid Brinsupri/Arikayce Growth, and Overdone Share Pullback

TIPRANKS
·
Jul 17

Insmed Says Treprostinil Shows Sustained Benefit to Pulmonary Arterial Hypertension Patients

MT Newswires Live
·
Jul 16

Insmed’s inhalation powder shows efficacy and safety in arterial hypertension

TIPRANKS
·
Jul 16

Insmed Reports Positive 12-month TPIP Extension Data in Pulmonary Arterial Hypertension Study

Reuters
·
Jul 16

Insmed - Tpip Safe and Well-tolerated with no New Safety Signals Through Month 12

THOMSON REUTERS
·
Jul 16

Insmed Announces Positive 12-month Data from the Ongoing Open-label Extension Study of Treprostinil Palmitil Inhalation Powder (tpip) in Patients with Pulmonary Arterial Hypertension

THOMSON REUTERS
·
Jul 16

Insmed - Placebo Crossed Group on Tpip Achieves Similar Outcomes to Tpip Continued Group at 12 Months

THOMSON REUTERS
·
Jul 16

Insmed - Tpip Demonstrates Sustained Improvement and Reduced Mortality Risk at 12 Months

THOMSON REUTERS
·
Jul 16

Insmed is Maintained at Overweight by Wells Fargo

Dow Jones
·
Jul 15

Barclays Remains a Buy on Insmed (INSM)

TIPRANKS
·
Jul 13

Insmed Chair, CEO William Lewis Sells 10,699 Shares for $1.26 Million

Reuters
·
Jul 11

Insmed Price Target Maintained with a $207.00/share by Guggenheim

Dow Jones
·
Jul 10

Insmed CMO Martina Flammer Disposes of Common Shares Worth $1.35 Million

Reuters
·
Jul 09

Analysts Are Bullish on These Healthcare Stocks: Insmed (INSM), Biogen (BIIB)

TIPRANKS
·
Jul 07

Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD) and Insmed (INSM)

TIPRANKS
·
Jun 29

Insmed Chair and CEO William Lewis Disposes of Common Shares Worth $2.21 Million

Reuters
·
Jun 27

Is Insmed (INSM) Cheap Following The EMBARC Partnership And Upcoming TPIP Data?

Simply Wall St.
·
Jun 26